Ignite Creation Date:
2024-05-06 @ 9:27 AM
Last Modification Date:
2024-10-26 @ 12:14 PM
Study NCT ID:
NCT02984995
Status:
COMPLETED
Last Update Posted:
2020-02-17
First Post:
2016-12-05
Brief Title:
Phase 2 Study of Quizartinib in Participants With Acute Myeloid Leukemia AML FLT3 Internal Tandem Duplication FLT3ITD Mutation
Sponsor:
Daiichi Sankyo Co Ltd
Organization:
Daiichi Sankyo
Organization Data
Organization:
Daiichi Sankyo
Class:
INDUSTRY
Study ID:
AC220-A-J201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Daiichi Sankyo Co Ltd
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Daiichi Sankyo | INDUSTRY |